| Title |
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening †
|
|---|---|
| Published in |
Annals of Oncology, September 2016
|
| DOI | 10.1093/annonc/mdw327 |
| Pubmed ID | |
| Authors |
S. Paluch-Shimon, F. Cardoso, C. Sessa, J. Balmana, M.J. Cardoso, F. Gilbert, E. Senkus, on behalf of the ESMO Guidelines Committee |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Venezuela, Bolivarian Republic of | 2 | 18% |
| United States | 2 | 18% |
| Spain | 1 | 9% |
| Netherlands | 1 | 9% |
| Unknown | 5 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 73% |
| Practitioners (doctors, other healthcare professionals) | 3 | 27% |
Mendeley readers
The data shown below were compiled from readership statistics for 591 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 591 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 81 | 14% |
| Researcher | 63 | 11% |
| Other | 50 | 8% |
| Student > Master | 50 | 8% |
| Student > Ph. D. Student | 49 | 8% |
| Other | 98 | 17% |
| Unknown | 200 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 220 | 37% |
| Biochemistry, Genetics and Molecular Biology | 72 | 12% |
| Nursing and Health Professions | 18 | 3% |
| Agricultural and Biological Sciences | 13 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 2% |
| Other | 52 | 9% |
| Unknown | 207 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2023.
All research outputs
#2,822,840
of 26,017,215 outputs
Outputs from Annals of Oncology
#1,551
of 7,962 outputs
Outputs of similar age
#46,788
of 353,959 outputs
Outputs of similar age from Annals of Oncology
#32
of 267 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,962 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,959 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 267 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.